Abstract
Many enzymes are subject to allosteric control, often with inhibitors and activators binding to the same effector site. Phosphofructokinase in Escherichia coli is such an enzyme, being inhibited by phosphoenolpyruvate (PEP) and activated by ADP and GDP1. How do individual interactions with effectors affect the balance between activation and inhibition, especially when both ligands share aspects of the same binding site? We find that mutation of a single residue in the effector site, Glu→Ala 187, leads to PEP being an activator rather than an inhibitor. With low concentrations of the substrate fructose-6-phosphate, the mutant enzyme is more than one hundred times more active than wild-type enzyme at millimolar concentrations of PEP. The classical Monod–Wyman–Changeux two-state model2 is too simple to account for the properties of the mutant enzyme.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Uyeda, K. Adv. Enzym. 48, 194–244 (1979).
Monod, J., Wyman, J. & Changeux, J. P. J. molec. Biol. 12, 88–118 (1965).
Blangy, D., Buc, H. & Monod, J. J. molec. Biol. 31, 13–35 (1968).
Evans, P. R., Farrants, G. W. & Lawrence, M. C. J. molec. Biol. 191, 713–720 (1986).
Evans, P. R. & Hudson, P. J. Nature 279, 500–504 (1979).
Nagai, K., Perutz, M. F. & Poyart, C. Proc. natn. Acad. Sci. U.S.A. 82, 7252–7255 (1985).
Ulmer, K. M. Science 219, 666–670 (1983).
Kotlarz, D. & Buc, H. Meth. Enzym. 90, 60–70 (1982).
Hellinga, H. W. & Evans, P. R. Eur. J. Biochem. 149, 363–373 (1985).
Dente, L., Cesareni, G. & Cortese, R. Nucleic Acids Res. 11, 1645–1655 (1983).
Zoller, M. J. & Smith, M. Meth. Enzym. 100, 468–500 (1983).
Gibson, T. J. thesis, Univ. Cambridge (1984).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tat-Kwong Lau, F., Fersht, A. Conversion of allosteric inhibition to activation in phosphofructokinase by protein engineering. Nature 326, 811–812 (1987). https://doi.org/10.1038/326811a0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/326811a0
This article is cited by
-
Allosteric receptors after 30 years
Rendiconti Lincei (2006)
-
Critical amino acids responsible for converting specificities of proteins and for enhancing enzyme evolution are located around β-turn potentials: Data-based prediction
Journal of Protein Chemistry (1993)
-
Genetic Approaches to Protein Structure and Function: Point Mutations as Modifiers of Protein Function
Nature Biotechnology (1992)
-
Inhibition into activation
Nature (1987)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.